Clinical auditing reveals significant misclassification in administrative codes for myocardial infarction (MI), with only 39% of type 1 (T1MI) codes and 72% of type 2 (T2MI) codes for the condition ...

N-terminal pro B-type peptide (NT-proBNP) has been associated with risk of myocardial infarction (MI), but less is known about the relationship between NT-proBNP and very small non ST-elevation MI, ...

Acute myocardial infarction (AMI) remains a leading cause of morbidity and mortality worldwide, primarily resulting from an abrupt coronary artery occlusion that deprives myocardial tissue of oxygen.

HealthDay News — For patients with type 2 diabetes, the risk of acute myocardial infarction (AMI) is not significantly different for long-acting insulin analogs versus other basal insulin therapies, ...

Tirzepatide is noninferior to dulaglutide regarding composite of death from CV causes, myocardial infarction, or stroke.

A report published in Circulation found the choice of general anesthetic may not affect the risk of myocardial infarction in patients undergoing non-cardiac surgery, according to News-Medical. A ...

Most trials that have shown a benefit of beta-blocker treatment after myocardial infarction included patients with large myocardial infarctions and were conducted in an era before modern ...

Slower heart rate recovery before PCI independently predicts periprocedural myocardial infarction and may improve cardiac risk assessment.